MSBIS: A Multi-Step Biomedical Informatics Screening Approach for Identifying Medications that Mitigate the Risks of Metoclopramide-Induced Tardive Dyskinesia

Article English OPEN
Xu, Dong; Ham, Alexandrea G.; Tivis, Rickey D.; Caylor, Matthew L.; Tao, Aoxiang; Flynn, Steve T.; Economen, Peter J.; Dang, Hung K.; Johnson, Royal W.; Culbertson, Vaughn L.;

In 2009 the U.S. Food and Drug Administration (FDA) placed a black box warning on metoclopramide (MCP) due to the increased risks and prevalence of tardive dyskinesia (TD). In this study, we developed a multi-step biomedical informatics screening (MSBIS) approach levera... View more
Share - Bookmark